Insights into next-generation immunotherapy designs and tools: molecular mechanisms and therapeutic prospects

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Immunotherapy, particularly CAR-T cell therapy, has transformed cancer treatment for blood cancers.
• Tumor resistance, driven by target heterogeneity and mutations, remains a significant challenge for current immunotherapies.
• Next-generation immunotherapeutic tools are emerging to address these limitations.

Purpose of the Study:

• To review molecular mechanisms and therapeutic potential of advanced immunotherapeutic strategies.
• To emphasize multi-targeting approaches for enhancing personalized immunotherapy efficacy.
• To discuss enabling technologies and future prospects in cancer immunotherapy.

Main Methods:

• Elucidation of molecular mechanisms underlying tumor resistance.
• Review of genetically engineered immune cells, multi-specific antibodies, and cell engagers.
• Exploration of logic gate modulation, adapter-mediated CARs, and AI in immunotherapy.

Main Results:

• Next-generation tools like logic gate circuits and adapter-mediated CARs can minimize adverse effects.
• Multi-specific antibodies and cell engagers offer enhanced tumor signal recognition.
• Gene delivery, gene editing, and AI show promise for tailored immunotherapy.

Conclusions:

• Multi-targeting strategies are crucial for overcoming tumor resistance and improving personalized immunotherapy.
• Advanced technologies like gene editing and AI are key to developing next-generation cancer treatments.
• Future research should focus on integrating these tools for more effective and safer cancer therapies.